Envestnet Asset Management »

Ishares Tr genomics immun shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Ishares Tr genomics immun (IDNA) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Ishares Tr genomics immun

Tip: Access up to 7 years of quarterly data

All positions including Ishares Tr genomics immun held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ishares Tr genomics immun by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $246k 9.4k 26.19
2023-09-30 $523k 26k 20.35
2023-06-30 $628k 27k 23.35
2023-03-31 $639k 28k 23.27
2022-12-31 $574k 23k 25.17

More positions owned by Envestnet Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr Core Univrsl Usd (IUSB)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Core Msci Emkt (IEMG)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Value Etf (VTV)
NVIDIA Corporation (NVDA)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 100 Etf (OEF)
Ishares Tr Core Us Aggbd Et (AGG)

View all positions for Envestnet Asset Management

Top funds holding Ishares Tr genomics immun

UBS Group
Wharton Business Group
Raymond James Financial
Portland Global Advisors
Ameriprise Financial
Royal Bank of Canada
LPL Financial
Jane Street
Flow Traders US
Bsc Private Wealth Management
Lido Advisors
Commonwealth Equity Services
Nelson, Van Denburg & Campbell Wealth Management
Citadel Advisors
C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors

View all funds holding Ishares Tr genomics immun